checkAd

     653  0 Kommentare Horizon Pharma plc to Acquire Worldwide Rights to Interferon Gamma-1b From Boehringer Ingelheim International GmbH - Seite 3

    Contacts:

    Investors:
    John Thomas
    Executive Vice President, Strategy and Investor Relations
    investor-relations@horizonpharma.com

    Tina Ventura
    Vice President, Investor Relations
    investor-relations@horizonpharma.com

    U.S. Media:
    Geoff Curtis
    Senior Vice President, Corporate Communications
    media@horizonpharma.com

    Ireland Media:
    Ray Gordon
    Gordon MRM
    ray@gordonmrm.ie

    Lesen Sie auch

    Diskutieren Sie über die enthaltenen Werte


    Seite 3 von 3

    Verfasst von Marketwired
    6 im Artikel enthaltene WerteIm Artikel enthaltene Werte
    Horizon Pharma plc to Acquire Worldwide Rights to Interferon Gamma-1b From Boehringer Ingelheim International GmbH - Seite 3 DUBLIN, IRELAND--(Marketwired - May 19, 2016) - Horizon Pharma plc (NASDAQ: HZNP) ("Horizon Pharma"), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and …